ACTA2 and Hepatic fibrosis: In addition, rottlerin treatment also suppressed TGFβ1-induced expression of ACTA2, COL1A1, COL1A2, and CCL2 (Figure 3C), the expression of which is greatly increased in HSCs of liver fibrosis patients.